INTERPACE BIOSCIENCES, INC. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2026.

Symbol
IDXG on OTC
Location
Parsippany, NJ
Fiscal year end
31 December
Latest financial report
30 Mar 2026

Latest SEC snapshot (2026-03-20) highlights Return On Equity 244.0%, Return On Assets 101.1%, and Operating Margin 10.5%.

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

79.9/100

Balanced Confidence medium

Return On Equity

244%

Metric score 100.0/100

Return On Assets

101%

Metric score 100.0/100

Financial Health

Current Ratio
1.94x
Quick Ratio
1.6x

Strengths

Return On Equity, Return On Assets, and Current Ratio

Watchpoints

Operating Margin and Revenues YoY

Key metrics snapshot

Return On Equity

244%

YoY: -1151%

Industry median: -18% (n=176)

View history

Return On Assets

101%

YoY: +110%

Industry median: -36% (n=175)

View history

Operating Margin

11%

YoY: -39%

Industry median: -17% (n=127)

View history

Current Ratio

1.94x

YoY: +75%

Industry median: 2.36x (n=176)

View history

Quick Ratio

1.6x

YoY: +70%

Industry median: 1.88x (n=146)

View history

Revenues YoY

-17%

YoY:

Industry median: 13% (n=42)

View history

NetIncomeLoss YoY

267%

YoY:

Industry median: 0.49% (n=168)

View history

Profitability

Metric Latest value YoY change
Return On Equity 244% -1151%
Return On Assets 101% +110%
Operating Margin 11% -39%

Financial Health

Metric Latest value YoY change
Current Ratio 1.94x +75%
Quick Ratio 1.6x +70%

Growth

Metric Latest value YoY change
Revenues YoY -17%
NetIncomeLoss YoY 267%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 27,700,904 +526%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%